Showing results (331-340 of 350) with videos related to
Sort By:
Pageof 35
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growthMichael H Muders, Pawan K Vohra, Shamit K Dutta, et al.Circulation Research|March 8, 2008
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibitionEric Arehart, Jeremiah Stitham, Folkert W Asselbergs, et al.Neuron|November 25, 2025
Resolving the mysteries of brain clearance and immune surveillanceJonathan Kipnis, Helene Benveniste, Anne Eichmann, et al.Journal of Neuroinflammation|February 2, 2025
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease modelsFelipe Saceanu Leser, Flavio de Souza Júnyor, Iohanna Bianca Pagnoncelli, et al.EMBO Molecular Medicine|January 23, 2014
VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heartRiikka Kivelä, Maija Bry, Marius R Robciuc, et al.Circulation Research|December 10, 2020
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic StrokeAnja Nitzsche, Marine Poittevin, Ammar Benarab, et al.Circulation Research|August 17, 2023
Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary HypertensionXiaofei Zhou, Yuanqing Jiang, Yuewen Wang, et al.Developmental Cell|June 3, 2006
Selective regulation of arterial branching morphogenesis by synectinThomas W Chittenden, Filip Claes, Anthony A Lanahan, et al.JCI Insight|December 22, 2017
Synectin promotes fibrogenesis by regulating PDGFR isoforms through distinct mechanismsMary C Drinane, Usman Yaqoob, Haibin Yu, et al.The Journal of Clinical Investigation|February 11, 2020
Chronic mTOR activation induces a degradative smooth muscle cell phenotypeGuangxin Li, Mo Wang, Alexander W Caulk, et al.Pageof 35